PET Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut.
Ministry of Education Key Laboratory of Radiopharmaceuticals, College of Chemistry, Beijing Normal University, Beijing, China.
J Nucl Med. 2017 Jun;58(6):982-988. doi: 10.2967/jnumed.116.188052. Epub 2017 Feb 23.
The σ receptors (S1Rs) are implicated in a variety of diseases including Alzheimer disease and cancer. Previous PET S1R radiotracers are characterized by slow kinetics or off-target binding that impedes their use in humans. Here, we report the first PET imaging evaluation in rhesus monkeys of 4 F-labeled spirocyclic piperidine-based PET radiotracers (F- to F-). Baseline scans for the 4 radiotracers were obtained on an adult male rhesus monkey. Blocking scans were obtained with the S1R-selective agonist SA4503 to assess binding specificity of F- and F- Arterial input functions were measured, and binding parameters were determined with kinetic modeling analysis. In the rhesus brain, all 4 radiotracers showed high and fast uptake. Tissue activity washout was rapid for F- and F-, and much slower for F- and F-, in line with their respective in vitro S1R-binding affinities. Both the 1-tissue-compartment and multilinear analysis-1 kinetic models provided good fits of time-activity curves and reliable estimates of distribution volume. Regional distribution volume values were highest in the cingulate cortex and lowest in the thalamus for all radiotracers. F- showed greater differential uptake across brain regions and 3-fold-higher binding potential than F- SA4503 at the dose of 0.5 mg/kg blocked approximately 85% (F-) and 95% (F-) of radiotracer binding. Tracers F- and F- displayed high brain uptake and fast tissue kinetics, with F- having higher specific binding signals than F- in the same monkey. Taken together, these data indicate that both F- and F- possess the requisite kinetic and imaging properties as viable PET tracers for imaging S1R in the human brain.
σ 受体(S1Rs)与多种疾病有关,包括阿尔茨海默病和癌症。以前的 PET S1R 放射性示踪剂的特点是动力学缓慢或存在非靶点结合,这阻碍了它们在人类中的应用。在这里,我们报告了首例使用恒河猴进行的 4 F 标记的螺环哌啶基 PET 放射性示踪剂(F-至 F-)的 PET 成像评估。在一只成年雄性恒河猴上获得了 4 种放射性示踪剂的基线扫描。使用 S1R 选择性激动剂 SA4503 进行阻断扫描,以评估 F-和 F-的结合特异性。测量了动脉输入函数,并通过动力学建模分析确定了结合参数。在恒河猴大脑中,所有 4 种放射性示踪剂都表现出高摄取和快速摄取。F-和 F-的组织活性清除迅速,而 F-和 F-的清除速度较慢,这与它们各自的体外 S1R 结合亲和力一致。1 组织室模型和多线性分析 1 动力学模型都对时间-活性曲线提供了良好的拟合,并对分布容积提供了可靠的估计。所有放射性示踪剂在大脑区域的分布容积值最高的是扣带皮层,最低的是丘脑。与 F-相比,F-在相同的猴子中表现出更高的脑区差异摄取和 3 倍更高的结合潜能。SA4503 在 0.5mg/kg 的剂量下,F-和 F-的结合分别被阻断约 85%(F-)和 95%(F-)。示踪剂 F-和 F-显示出高脑摄取和快速组织动力学,F-在同一猴子中的特异性结合信号高于 F-。总之,这些数据表明,F-和 F-都具有作为 S1R 在人脑中成像的可行 PET 示踪剂所需的动力学和成像特性。